Unanswered questions in the use of blood component therapy in trauma
2011

Questions About Blood Component Therapy in Trauma

Commentary

Author Information

Author(s): Allen Steven R, Kashuk Jeffry L

Primary Institution: Penn State Hershey Medical Center, College of Medicine

Conclusion

Recent advances in blood component therapy for trauma have not significantly reduced mortality from trauma-induced coagulopathy over the past 30 years.

Supporting Evidence

  • Mortality from trauma-induced coagulopathy has not changed significantly over the past 30 years.
  • Recent evidence suggests that coagulopathy can occur prior to fluid resuscitation.
  • Monitoring coagulation function in trauma patients may improve treatment outcomes.

Takeaway

Doctors are trying to figure out the best way to use blood products to help people who are hurt badly, but it's still a tough problem after many years.

Potential Biases

Potential biases in the interpretation of data due to differences in transfusion practices.

Limitations

The commentary discusses ongoing controversies and lacks definitive conclusions due to varying protocols and retrospective data.

Digital Object Identifier (DOI)

10.1186/1757-7241-19-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication